Financials
- Market Capitalization 2.23 B
- Employee 76
- Founded 2019
- CEO N/A
- Website mineralystx.com
- Headquarter Delaware, United States
- FIGI BBG00ZXN1GN3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1899 | PHVS Pharvaris N.V. - Ordinary Shares | 35.25 USD | +2.41% | -1.59% | +11.16% | +53.59% | 2.30 B USD | ||
| 1918 | BHVN Biohaven Ltd. Common Shares | 14.84 USD | -0.67% | -7.02% | +22.64% | -12.41% | 2.23 B USD | ||
| 1938 | OCUL Ocular Therapeutix, Inc. - Common Stock | 9.83 USD | +1.34% | -4.00% | +9.34% | -14.52% | 2.15 B USD | ||
| 1951 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 23.87 USD | -1.08% | -3.20% | +28.96% | +159.17% | 2.12 B USD |
Frequently asked questions about Mineralys Therapeutics, Inc. - Common Stock
What is the Mineralys Therapeutics, Inc. - Common Stock stock price today?
The current price of Mineralys Therapeutics, Inc. - Common Stock (MLYS) is 27.08. Over the past 24 hours, the stock has changed by -0.73%. Follow the MLYS chart for real-time price dynamics.
What is the stock ticker of Mineralys Therapeutics, Inc. - Common Stock?
Mineralys Therapeutics, Inc. - Common Stock trades under the ticker MLYS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Mineralys Therapeutics, Inc. - Common Stock stock going up?
MLYS has changed by -10.18% over the last week, +12.93% over the last month, and -32.92% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Mineralys Therapeutics, Inc. - Common Stock net income for the last quarter?
Mineralys Therapeutics, Inc. - Common Stock reported net income of -39.34 M for the last quarter. The previous quarter showed -32.23 M, which means net income changed by -22.04%.
How many employees does Mineralys Therapeutics, Inc. - Common Stock have?
As of the latest available data, Mineralys Therapeutics, Inc. - Common Stock has 76 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Mineralys Therapeutics, Inc. - Common Stock stock?
You can buy Mineralys Therapeutics, Inc. - Common Stock (MLYS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Mineralys Therapeutics, Inc. - Common Stock stock?
Investing in Mineralys Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MLYS chart and related analysis on metatrader.com as part of your research.